WOR.AU

13.85

-0.22%↓

WOR.AU

13.85

-0.22%↓

WOR.AU

13.85

-0.22%↓

WOR.AU

13.85

-0.22%↓

WOR.AU

13.85

-0.22%↓

Search

McMillan Shakespeare Ltd

Geschlossen

BrancheIndustrie

15.98 -0.5

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

15.95

Max

16.33

Schlüsselkennzahlen

By Trading Economics

Einkommen

45M

Verkäufe

277M

KGV

Branchendurchschnitt

11.854

39.332

EPS

0.65

Dividendenrendite

9.19

Gewinnspanne

16.336

Angestellte

1,311

EBITDA

114M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+21.33% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

9.19%

2.46%

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

142M

1.2B

Vorheriger Eröffnungskurs

16.48

Vorheriger Schlusskurs

15.98

Nachrichtenstimmung

By Acuity

16%

84%

25 / 458 Ranking in Industrials

McMillan Shakespeare Ltd Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

5. Nov. 2025, 23:51 UTC

Ergebnisse

CoreCivic Cuts Fiscal Year Guidance Amid Efforts to Launch New Detention Facilities

5. Nov. 2025, 23:10 UTC

Ergebnisse

DBS Third Quarter Net Dips 2.0%

5. Nov. 2025, 22:55 UTC

Ergebnisse

Arm Holdings 2Q Profit Climbs on Record Demand

5. Nov. 2025, 22:23 UTC

Ergebnisse

NAB's Annual Profit Falls 2.9% Amid Higher Costs, Credit Impairments -- Update

5. Nov. 2025, 23:52 UTC

Ergebnisse

United Overseas Bank 3Q Net Interest Income S$2.265B Vs. $2.46B >U11.SG

5. Nov. 2025, 23:49 UTC

Ergebnisse

United Overseas Bank 3Q Total Income S$3.40B Vs. S$3.83B >U11.SG

5. Nov. 2025, 23:49 UTC

Ergebnisse

United Overseas Bank 3Q Net S$443M Vs. Net S$1.61B >U11.SG

5. Nov. 2025, 23:45 UTC

Market Talk

Nikkei May Rise on Weaker Yen, U.S. Tech Rebound -- Market Talk

5. Nov. 2025, 23:42 UTC

Market Talk

Gold Edges Lower Amid Reduced Odds of Fed Rate-Cut -- Market Talk

5. Nov. 2025, 23:12 UTC

Ergebnisse

Nutrien 3Q Adj EPS 97c >NTR.T

5. Nov. 2025, 23:11 UTC

Ergebnisse

Nutrien: Initiating Review of Strategic Alternatives for Phosphate Business >NTR.T

5. Nov. 2025, 23:10 UTC

Ergebnisse

Nutrien 3Q Sales $6.01B >NTR.T

5. Nov. 2025, 23:10 UTC

Market Talk
Ergebnisse

AppLovin Says Conversion Rate Is Biggest Growth Lever -- Market Talk

5. Nov. 2025, 23:10 UTC

Ergebnisse

Nutrien 3Q EPS 96c >NTR.T

5. Nov. 2025, 23:04 UTC

Ergebnisse

Qualcomm Stock Slides After Earnings Beat -- Barrons.com

5. Nov. 2025, 23:03 UTC

Market Talk

Macklem: Canada's Regulatory Overlap Turns Off Foreign Investors -- Market Talk

5. Nov. 2025, 22:55 UTC

Market Talk

Macklem Says Inflation and Productivity Are Intertwined -- Market Talk

5. Nov. 2025, 22:55 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Up. -- Barrons.com

5. Nov. 2025, 22:51 UTC

Ergebnisse

DBS 3Q Total Income S$5.93B, Up 3% on Year >D05.SG

5. Nov. 2025, 22:50 UTC

Ergebnisse

DBS 3Q Net S$2.95B, Down 2.0% on Year >D05.SG

5. Nov. 2025, 22:44 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Preps Improved Offer in Metsera Bidding War -- Update

5. Nov. 2025, 22:43 UTC

Market Talk
Ergebnisse

NAB's Flat Dividend Disappoints Bears at Jarden -- Market Talk

5. Nov. 2025, 22:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

5. Nov. 2025, 22:36 UTC

Market Talk

Macklem Warns Structural Adjustment Means Slow Canadian Growth -- Market Talk

5. Nov. 2025, 22:20 UTC

Market Talk

Bank of Canada Says Budget Plan Identifies Economy's Biggest Weakness -- Market Talk

5. Nov. 2025, 22:12 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer: Will Take Action to Preserve Rights Under Previously-Signed Agreement >PFE

5. Nov. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer: Confident in Merits of Claims, Belief Metsera Has Acted in Breach of Contractual Obligations >PFE

5. Nov. 2025, 22:11 UTC

Akquisitionen, Fusionen, Übernahmen

Pfizer Responds to Delaware Chancery Court Ruling

5. Nov. 2025, 22:01 UTC

Ergebnisse

Great-West Lifeco 3Q Net C$1.16B >GWO.T

5. Nov. 2025, 22:01 UTC

Ergebnisse

Great-West Lifeco 3Q Adj EPS C$1.33 >GWO.T

Peer-Vergleich

Kursveränderung

McMillan Shakespeare Ltd Prognose

Kursziel

By TipRanks

21.33% Vorteil

12-Monats-Prognose

Durchschnitt 19.704 AUD  21.33%

Hoch 21 AUD

Tief 18.1 AUD

Basierend auf 5 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McMillan Shakespeare Ltd – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

5 ratings

3

Buy

2

Halten

0

Sell

Stimmung

By Acuity

25 / 458 Ranking in Industrie

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McMillan Shakespeare Ltd

McMillan Shakespeare Limited provides salary packaging, novated leasing, disability plan management, support co-ordination, asset management, and related financial products and services in Australia and New Zealand. It operates through Group Remuneration Services, Asset Management Services, and Plan and Support Services segments. The Group Remuneration Services segment offers salary packaging and ancillary services, including novated leasing asset and finance procurement, motor vehicle administration, and other services. The Asset Management Services segment provides financing and ancillary management services related with motor vehicles, commercial vehicles, and equipment. The Plan and Support Services segment offers plan management and support coordination services to participants in the national disability insurance scheme. It serves federal and state governments, public and private sectors, and health and charitable organizations. The company founded in 1988 and is headquartered in Melbourne, Australia.
help-icon Live chat